Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 17 of 17 entries
View as:

Lesional Evaluation of High Risk Patients With Neoatherosclerosis Treated With Rosuvastatin and Eicosapentaenoic Acid Using Optical Coherence Tomography(OCT)[LINK IT TWO]

Phase: N/A Priority: Normal
NCT ID: NCT03657758 Org: User:
Start: 09/17/18 End: 08/31/21 Due: 08/31/22

A Extension Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance ( EMPIRE-02 )

Phase: N/A Priority: Normal
NCT ID: NCT04221152 Org: User:
Start: 02/01/20 End: 05/31/22 Due: 05/31/23

Quality of Sleep in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00287794 Org: User:
Start: 02/28/06 End: 12/31/10 Due: 12/31/11

Healing Response to Everolimus-eluting Stent Implantation; Serial Assessment With opticaL Coherence Tomography

Phase: N/A Priority: Normal
NCT ID: NCT01689688 Org: User:
Start: 09/30/12 End: 10/31/15 Due: 10/31/16

Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT01918384 Org: User:
Start: 08/31/13 End: 10/31/15 Due: 10/31/16

A Prospective Randomized Controlled Multicenter Trial of Delayed Gastric Emptying (DGE) After Pancreaticoduodenectomy Evaluating by Gastrointestinal Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT01460550 Org: User:
Start: 11/30/11 End: 03/31/17 Due: 03/31/18

Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial

Phase: N/A Priority: Normal
NCT ID: NCT03192579 Org: User:
Start: 07/26/13 End: 06/02/17 Due: 06/02/18

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent

Phase: N/A Priority: Normal
NCT ID: NCT02014818 Org: User:
Start: 01/31/14 End: 12/31/18 Due: 12/31/19

Comparisons of Morphological Measurement Between Coronary Computed Tomography and Optical Coherence Tomography

Phase: N/A Priority: Normal
NCT ID: NCT03021382 Org: User:
Start: 07/31/16 End: 08/31/16 Due: 08/31/17

Relation Among HDL Functionality, Neoatherosclerosis and Target Lesion Revascularization

Phase: N/A Priority: Normal
NCT ID: NCT03540381 Org: User:
Start: 05/01/11 End: 07/31/17 Due: 07/31/18

Effect of Alirocumab(Proprotein Convertase Subtilisin/Kexin type9 Inhibitor) and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaques in Coronary Artery Disease Evaluated by Near-infrared Spectroscopy Intravascular Ultrasound

Phase: N/A Priority: Normal
NCT ID: NCT03529253 Org: User:
Start: 04/01/18 End: 09/30/20 Due: 09/30/21

The Efficacy of Alirocumab for Thin-cap fIbroatheroma in Patients With Coronary Artery Disease Estimated by Optical Coherence Tomography

Phase: N/A Priority: Normal
NCT ID: NCT03552432 Org: User:
Start: 08/23/17 End: 09/30/21 Due: 09/30/22

Protective Effect of EPA on Cardiovascular Events

Phase: N/A Priority: Normal
NCT ID: NCT00231738 Org: User:
Start: 11/30/96 End: 11/30/04 Due: 11/30/05

A Study of Empagliflozin in Patients With Refractory Diabetes Mellitus With Insulin Resistance

Phase: N/A Priority: Normal
NCT ID: NCT04018365 Org: User:
Start: 09/01/19 End: 10/30/21 Due: 10/30/22

Relation Among Shear Stress Distribution, Stent Design, and Subsequent Vessel Healing After Drug-eluting Stent Implantation (SHEAR DES)

Phase: N/A Priority: Normal
NCT ID: NCT01942044 Org: User:
Start: 02/28/13 End: 02/28/15 Due: 02/28/16

To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03533959 Org: User:
Start: 12/18/17 End: 12/31/25 Due: 12/31/26

Evaluation of Fractional Flow Reserve Calculated by Computed Tomography Coronary Angiography in Patients Undergoing TAVR

Phase: N/A Priority: Normal
NCT ID: NCT03665389 Org: User:
Start: 09/13/18 End: 03/31/22 Due: 03/31/23